|
|
Office Locations:
|
399 Revolution Drive, Suite 955
Somerville, MA 02145
Phone: 857-307-2400
| |
|
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Partners HealthCare Innovation is advancing commercialization of new medical technologies from Partners' academic medical centers. Bringing together specialists in medical technology licensing, research contracts, ventures and business development, they partner with investigators, scientists and clinicians to translate new medical technology into healthcare practice via a variety of business channels. Representing Brigham and Women's Hospital, Massachusetts General Hospital, and McLean Hospital, Partners HealthCare is the largest academic biomedical research enterprise in the US. They are committed to a creative, solutions-oriented approach to licensing, ventures and research that delivers opportunities to improve patient care around the world. Innovation is the 120-person business development unit of Partners HealthCare responsible for the worldwide commercial application of the unique capabilities and discoveries of Partners' 74,000 employees
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
